文献速递免疫规划传染病防控与疫情报告卫生政策与健康促进

全球麻疹消除进展——2000-2023年

Progress Toward Measles Elimination - Worldwide, 2000-2023.
PubMed 文献 · MMWR Morb Mortal Wkly Rep · 2024-11-14

本报告描述2000-2023年全球麻疹消除进展。COVID-19大流行期间MCV1覆盖率降至81%(2008年以来最低),2022年回升至83%后2023年持平;

要点

  • MCV1全球覆盖率在COVID-19大流行期间降至81%,2022年回升至83%,2023年持平。
  • 2022至2023年估计麻疹病例增加20%,大规模或破坏性疫情国家从36个增至57个,估计死亡下降8%。

核心结论

  • 尽管所有六个世界卫生组织区域均承诺消除麻疹,但截至2023年底尚无区域成功实现并维持麻疹消除。
  • MCV1覆盖率停滞意味着数百万儿童仍未受到保护,导致病例和疫情增加。
  • 需要紧急和有针对性的努力,确保所有儿童接种2剂MCV并加强监测,以加快麻疹消除进展。

研究设计与样本

  • 本报告描述2000-2023年全球麻疹消除进展,数据来自世界卫生组织六个区域的估计。

主要发现

  • COVID-19大流行期间全球MCV1估计覆盖率降至81%(2008年以来最低),2022年回升至83%,2023年持平。
  • 2022至2023年全球估计麻疹病例增加20%,从8,645,000例增至10,341,000例。
  • 发生大规模或破坏性疫情的国家从2022年36个增至2023年57个。
  • 估计麻疹死亡下降8%,从2022年116,800例降至2023年107,500例,主要因更多病例发生在死亡风险较低的国家。

临床怎么用

  • 需要紧急和有针对性的努力,确保所有儿童接种2剂MCV并加强监测,以加快麻疹消除进展。
  • 低收入国家及脆弱、受冲突影响和易受伤害环境的国家MCV覆盖率更低、麻疹发病率更高,加剧了不平等。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Measles vaccination effectively prevents measles, a highly contagious disease that can cause severe complications and death and requires high population immunity to interrupt transmission. This report describes measles elimination progress during 2000-2023. During 2000-2023, an estimated 60.3 million measles deaths were averted by vaccination. However, despite commitment from all six World Health Organization regions to eliminate measles, no region has successfully achieved and maintained measles elimination as of the end of 2023. During the COVID-19 pandemic, estimated global coverage with the first dose of measles-containing vaccine (MCV1) declined to 81%, the lowest level since 2008. MCV1 coverage improved to 83% in 2022 but was unchanged in 2023. From 2022 to 2023, estimated measles cases increased 20% worldwide, from 8,645,000 to 10,341,000; the number of countries experiencing large or disruptive outbreaks increased from 36 to 57. Estimated measles deaths decreased 8%, from 116,800 in 2022 to 107,500 in 2023, primarily because an increased number of cases occurred in countries with lower risk for death. The stagnation in MCV1 coverage means millions of children remain unprotected, leading to increases in cases and outbreaks. Coverage with measles-containing vaccine (MCV) is lower, and measles incidence is higher, in low-income countries and countries experiencing fragile, conflict-affected, and vulnerable settings, which exacerbate inequities. Urgent and targeted efforts are needed to ensure that all children receive 2 MCV doses and that surveillance is strengthened to hasten progress toward measles elimination.

来源:MMWR Morb Mortal Wkly Rep,查看原文。版权归原作者所有。

引用

  1. Minta AA, Ferrari M, Antoni S, et al. Progress Toward Measles Elimination - Worldwide, 2000-2023. MMWR Morb Mortal Wkly Rep. 2024. PMID: 39541251. doi:10.15585/mmwr.mm7345a4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。